How Torrent Pharma is integrating Unichem to boost its domestic business

The Ahmedabad-based pharma company plans to launch its first product from Bio-Pharm stable this quarter in the US; Unichem MR attrition rate has halved in the hope of a turnaround

Ahmedabad-based drug company Torrent Pharmaceuticals, which has faced a slowdown in its US business, has now turned its focus on growing its domestic business. The company hopes to clock 25 per cent compound annual growth rate (CAGR) for its India business over the next three years to beat the slowdown in other geographies.

Besides, the pharmaceutical firm is working actively on integrating the portfolio Unichem, whose branded business it acquired in November last year. And, it is also set to launch the first product from the stable of its recent US acquisition, Bio-Pharm Inc.

The domestic formulations business accounts for